CCDC80 and metabolic dysfunction-associated steatohepatitis: ,63 We observed significantly increased differential expression of CCDC80 in individuals with NAFLD, using 3 independent tests comparing individuals with steatosis, fibrosis, and NASH to those with healthy livers.